SATB2 and colorectal carcinoma: Eberhard et al. [33] reported that elevated SATB2 expression was correlated with prolonged cancer‐specific survival and overall survival in CRC patients, serving as an independent marker of good prognosis in patients with colon cancer but not in those with rectal cancer, similar to the findings of Mezheyeuski et al. [34].